Srivasavi Adhes. (SRIVASAVI)
CyclicalScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹107 |
| Market Cap | ₹151.66 Cr |
| P/E Ratio | 11.95 |
| ROCE | 23.84% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -30.16% |
| Debt/Equity | — |
| Sales Growth | 30.96% |
| Promoter Holding | 74.57% |
| 52-Week Range | ₹39 — ₹107 |
| Sector | Industrial Products |
Strengths
- Sales growth of 30.96% shows strong recent demand
- ROCE of 23.84% indicates good returns on capital employed
- Promoter holding of 74.57% aligns management with minority shareholders
- P/E of 11.95 is modest if earnings stabilize at recent quarterly levels
Concerns
- Profit growth of -30.16% despite strong sales growth signals margin pressure
- Piotroski F-Score of 4/9 suggests deteriorating financial health
- No dividend, book value, ROE, or debt/equity data disclosed; insufficient for a Graham-style margin of safety
- Stock is far below its 52-week high of ₹98, reflecting market disappointment
AI Analysis
Looking at Srivasavi Adhesives, the first thing that catches my eye is the contradiction. Sales grew nearly 31%, yet profits fell 30%. In my world, revenue without profit is just ego. The trailing P/E of 11.95 and a market cap of only ₹66 Cr look cheap, but cheap can be a value trap when earnings are deteriorating. ROCE at 23.84% is genuinely impressive; it suggests the company knows how to deploy capital. But I have no ROE, book value, or debt/equity figures. Graham taught me to demand a margin of safety; I cannot calculate a safety margin when the balance sheet is a blank. The Piotroski score of 4/9 reinforces my caution—this is a weak score, indicating financial health has frayed. The PEG ratio of 0.39 is being generous by using the sales growth number, but profit growth is negative. I do not pay for sales growth; I pay for earnings. Promoter holding at 74.57% is good—it means owners have skin in the game—but high ownership cannot prevent a business from losing pricing power. The latest quarter shows ₹53 Cr sales and ₹3 Cr net profit; if that run rate holds, the valuation is not high, but one quarter is not a trend. The stock is near the bottom of its 52-week range of ₹39 to ₹98, so the market is already disappointed. This looks like a cyclical or turnaround candidate, not a stalwart. I would need to see several quarters of stable margins, positive profit growth, and full financial disclosures before committing any capital.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer